Retatutride: How the hunger for a new weight loss drug is feeding an industry of fakes
- Excitement around the creation of a new drug, especially one showing early promise in clinical trials, is often celebrated by those developing it.
- But new weight-loss drug retatrutide has become a headache not only for Eli Lilly, the pharmaceutical company behind it, but for regulators in the UK and around the world.
- The jab has not yet been approved for human use by any regulatory body.
Unverified
- Excitement around the creation of a new drug, especially one showing early promise in clinical trials, is often celebrated by those developing it.
- But new weight-loss drug retatrutide has become a headache not only for Eli Lilly, the pharmaceutical company behind it, but for regulators in the UK and around the world.
- The jab has not yet been approved for human use by any regulatory body.
Sources: BBC News